<DOC>
	<DOCNO>NCT00130546</DOCNO>
	<brief_summary>The main objective study assess safety effectiveness Sirolimus elute Cypher Select ( TM ) stent reduce angiographic in-stent late loss de novo native coronary lesion compare TAXUS ( TM ) Paclitaxel-eluting stent patient present two coronary artery stenosis ( prospective , randomize , intra-individual comparison ) .</brief_summary>
	<brief_title>Intra-Individual Comparison Sirolimus Paclitaxel Coated Stent ( FRE-RACE Study )</brief_title>
	<detailed_description>This prospective , 2 arm , randomize , multicenter Phase III study ( 6 center ) . A total 110 patient least two de novo native coronary artery lesion ( lesion A , lesion B ) ≤ 30 mm length ≥ 2.25 mm &lt; 3.0 mm diameter visual estimate enrol . Patients randomized implantation sirolimus elute Cypher Select ( TM ) Balloon-Expandable Stent TAXUS ( TM ) Paclitaxel-eluting stent lesion A B .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>The patient must &gt; =18 &lt; =85 year age Female childbearing potential must negative pregnancy test time enrolment utilize reliable birth control duration participation trial Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS I , II , III , IV ) OR unstable angina pectoris ( Braunwald Classification B &amp; C , IIIIII ) document ischemia OR patient document silent ischemia Two de novo lesion &lt; 30 mm length ( visual estimate ) Target vessel lesion site ≥ 2.25 mm ≤ 3.0 mm diameter ( visual estimate ) Target lesion locate native coronary artery cover one stent ( single lesion ) Acceptable candidate coronary artery bypass surgery ( CABG ) Target lesion stenosis &gt; 50 % &lt; 100 % ( thrombolysis myocardial infarction [ TIMI ] 1 ) ( visual estimate ) Target lesion differ length 6 mm Patient willing comply specify followup evaluation Patient must provide write informed consent prior procedure use form approve local Ethics Committee Qwave nonQwave myocardial infarction within precede 72 hour unless CK CKMB enzymes back normal Unprotected leave main coronary disease &gt; = 50 % stenosis Impaired runoff treatment vessel diffuse distal disease Ostial target lesion Angiographic evidence thrombus within target lesion Calcified lesion successfully predilated Ejection fraction &lt; = 30 % Totally occluded vessel ( TIMI 0 level ) Impaired renal function ( creatinine &gt; 3.0 mg/dl ) Pretreatment device balloon angioplasty Target lesion excessive tortuosity unsuitable stent delivery deployment Target lesion involve bifurcation include side branch &gt; = 2.5 mm diameter ( either stenosis main vessel major branch stenosis major branch ) would require side branch stenting likely occur side branch diseased intend stented Prior stent within 5 mm target lesion include instent restenosis Significant ( &gt; 50 % ) untreated stenosis proximal distal target lesion treat procedure may require revascularization impede runoff Intervention another lesion occur within one month plan highly probable perform within next 30 day index procedure Recipient heart transplant Patient life expectancy le 12 month Known allergy aspirin , clopidogrel bisulfate ( Plavix® ) , ticlopidine ( Ticlid® ) , heparin stainless steel , contrast agent , Paclitaxel Sirolimus Any significant medical condition investigator 's opinion may interfere patient 's optimal participation study Target lesion locate arterial venous bypass graft Currently participate investigational drug another device study Unstable angina pectoris Braunwald Classification A IIIIII periinfarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>coronary intervention</keyword>
	<keyword>drug elute stent implantation</keyword>
	<keyword>Cypher - Stent</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Taxus - Stent</keyword>
	<keyword>Paclitaxel</keyword>
</DOC>